a 2007

Nutrient-gene interactions in diabetes - advanced glycation end products (AGEs)

KAŇKOVÁ, Kateřina

Základní údaje

Originální název

Nutrient-gene interactions in diabetes - advanced glycation end products (AGEs)

Název česky

Nutrient-gene interactions in diabetes - advanced glycation end products (AGEs)

Autoři

KAŇKOVÁ, Kateřina (203 Česká republika, garant)

Vydání

The Nutrition Society: Diet and Chronic Disease, 2007

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30202 Endocrinology and metabolism

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/07:00019461

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Advanced Glycation End-products; RAGE; Maillard Reaction; nutrigenetics

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 2. 4. 2010 15:06, prof. MUDr. Kateřina Kaňková, Ph.D.

Anotace

V originále

Complex chemical processes called non-enzymatic glycation and glycoxidation taking place in vivo and analogical chemical interactions between sugars and proteins occurring during thermal processing of food (know to the food chemists long ago thanks to the pioneering studies of Louis Camille Maillard almost a century ago) are one of the interesting examples of potentially harmful interaction between nutrition and disease. Non-enzymatic glycation comprise a series of reactions between sugars, a-oxoaldehydes and other sugar derivatives and proteins finally leading - through the early and intermediate stages - to the formation of heterogeneous moieties collectively called Advanced Glycation End-products (AGEs) possessing a wide range of human medicine-related chemical and biological effects. Large body of evidence support causal involvement of glycoxidation and AGEs in the development and/or progression of diabetes-related pathology as wells as several other diseases. Nevertheless, diabetes is of main interest for several reasons: (i) its principal pathogenic feature - chronic hyperglycemia - feeds the substrates for the extra- as well as intracellular glycation, (ii) sustained hyperglycaemia-induced overproduction of superoxide in mitochondrial respiratory chain accelerates AGE formation in the process of glycoxidation, (iii) AGE-modified proteins are subjects of rapid intracellular proteolytic degradation releasing free AGE-adducts into the circulation where they can bind to several pro-inflammatory receptors, especially Receptor of AGEs (RAGE), and, finally, (iv) kidneys are principally involved in the excretion of AGEs and kidney damage (i.e. diabetic nephropathy) is one of the common and unfortunate complications of diabetes further enhancing AGE-toxicity due to diminished AGE clearance. Increased dietary intake of AGEs in highly processed foods by diabetics might thus represent an additional metabolic burden on top of already mentioned alterations. Finally, genetic variability in a class of genes encoding enzymes and receptors involved in either formation or degradation of AGEs (so called "glycoxidation-related genes") is a subject of intense research since an interindividual functional variability in metabolic systems dealing with glycoxidation could have a significant nutrigenomic and nutrigenetic consequences.

Česky

Complex chemical processes called non-enzymatic glycation and glycoxidation taking place in vivo and analogical chemical interactions between sugars and proteins occurring during thermal processing of food (know to the food chemists long ago thanks to the pioneering studies of Louis Camille Maillard almost a century ago) are one of the interesting examples of potentially harmful interaction between nutrition and disease. Non-enzymatic glycation comprise a series of reactions between sugars, a-oxoaldehydes and other sugar derivatives and proteins finally leading - through the early and intermediate stages - to the formation of heterogeneous moieties collectively called Advanced Glycation End-products (AGEs) possessing a wide range of human medicine-related chemical and biological effects. Large body of evidence support causal involvement of glycoxidation and AGEs in the development and/or progression of diabetes-related pathology as wells as several other diseases. Nevertheless, diabetes is of main interest for several reasons: (i) its principal pathogenic feature - chronic hyperglycemia - feeds the substrates for the extra- as well as intracellular glycation, (ii) sustained hyperglycaemia-induced overproduction of superoxide in mitochondrial respiratory chain accelerates AGE formation in the process of glycoxidation, (iii) AGE-modified proteins are subjects of rapid intracellular proteolytic degradation releasing free AGE-adducts into the circulation where they can bind to several pro-inflammatory receptors, especially Receptor of AGEs (RAGE), and, finally, (iv) kidneys are principally involved in the excretion of AGEs and kidney damage (i.e. diabetic nephropathy) is one of the common and unfortunate complications of diabetes further enhancing AGE-toxicity due to diminished AGE clearance. Increased dietary intake of AGEs in highly processed foods by diabetics might thus represent an additional metabolic burden on top of already mentioned alterations. Finally, genetic variability in a class of genes encoding enzymes and receptors involved in either formation or degradation of AGEs (so called "glycoxidation-related genes") is a subject of intense research since an interindividual functional variability in metabolic systems dealing with glycoxidation could have a significant nutrigenomic and nutrigenetic consequences.

Návaznosti

GP303/02/D127, projekt VaV
Název: Vztah genetické variability antioxidačního systému k pozdním komplikacím diabetu mellitu
Investor: Grantová agentura ČR, Vztah genetické variability antioxidačního systému k pozdním komplikacím diabetu mellitu
KJB501620601, projekt VaV
Název: Funkční analýza rizikového haplotypu RAGE genu a jeho role v patogenezi hyperglykemií indukovaných změn
Investor: Akademie věd ČR, Funkční analýza rizikového haplotypu RAGE genu a jeho role v patogenezi hyperglykemií indukovaných změn